Recent advances in coeliac disease

Clinical Medicine

Volumn 3, Issue 2, 2003, Pages 166-169

  Ciclitira, Paul J ^a,b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Coeliac disease; Gluten; Immunodominant epitopes; Pathogenesis; Serological screening

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EPITOPE; GLIADIN; GLUTEN; HLA DQ ANTIGEN; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G;

CAUSE OF DEATH; CELIAC DISEASE; CEREAL; CHEMICAL ANALYSIS; CHROMOSOME 2Q; CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; DISEASE EXACERBATION; EARLY DIAGNOSIS; GENETIC ANALYSIS; HIGH RISK POPULATION; HUMAN; INTESTINE BIOPSY; INTESTINE MUCOSA PERMEABILITY; INTESTINE VILLUS; MORTALITY; OAT; PATHOGENESIS; PREVALENCE; PROTEIN RESTRICTION; RYE; SCREENING; SEROLOGY; T LYMPHOCYTE; WHEAT;

EID: 0037365323     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.3-2-166     Document Type: Conference Paper

References (36)

1. Gee S. On the coeliac affection. St Bartholomew's Hospital Journal 1888;24:17-20.
2. West J, Lloyd CA, Reader R, Hill PG et al. Prevalence of undiagnosed coeliac disease in the general population of England. Gut 2001; 48(Suppl 1):A237.
3. Not T, Horvath K, Hill ID, Partanen J et al. Coeliac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol 1998;33:494-8.
4. Ivarsson A, Persson LA, Juto P, Peltonen et al. High prevelaence of undiagnosed coeliac disease in adults: a Swedish population based study. J Intern Med 1999;245:63-8.
5. Johnston SD, Watson RG, McMillan SA, Sloan J, Love AH. Coeliac disease detected by screening is not silent - simply unrecognised. QJM 1998;91(12):853-60.
6. Not T, Tommasini A, Tonini G, Burratti E et al. Undiagnosed coeliac disease and risk of autoimmune disorders in subjects with Type I diabetes mellitus. Diabetologia 2001;44(2):151-5.
7. Matteoni CA, Goldblum JR, Wang N, Brzezinski A et al. Coeliac disease is highly prevalent in lymphocytic colitis. J Clin Gastroenterol 2001;32: 225-7.
8. Gilet HR, Freeman HI. Prevalence of coeliac disease in collagenous and lymphocytic colitis. Can J Gastroenterol 2000;14:919-21.
9. Hin H, Bird G, Fisher P, Mahy N, Jewell D. Coeliac disease in primary care: a case finding study. Br Med J 1999;318:164-7.
10. Corrao G, Corazza G, Bagnardi V, Brusco D et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 2001;358:356-61.
11. Corrao G, Corrazza GR, Andreani ML, Torchio P et al. Serological screening of coeliac disease: choosing the optimal procedure according to prevalence values. Gut 1994;35:771-5.
12. Yiannakou JY, Dell'ollio D, Saaka M, Ellis HJ et al. Detection and characterisation of anti-endomysial antibody in coeliac disease using human umbilical cord. Int Arch Allergy Imunol 1997;112:140-144.
13. Valdimarsson T, Frazen L, Grodizinsky E, Skogh T et al. Is small bowel biopsy necessary in adults with suspected coeliac disease and IgA antiendomysial antibodies? Dig Dis Sci 1991;36:752-6.
14. Baldas V, Tommasini A, Trevisiol C, Berti I et al. Development of a novel rapid non-invasive screening test for coeliac disease. Gut 2000;47:628-31.
15. Cataldo F, Lio D, Marino V, Picarelli A et al. IgG1 antiendomyseum and IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IA deficiency. Gut 2000;47:366-9.
16. Baldas V, Tommasini A, Trevisiol C, Berti I et al. Development of a novel rapid non-invasive screening test for coeliac disease. Gut 2000, 47:628-31.
17. Petronzelli F, Bonamico M, Ferrante P, Grillo R et al. Genetic contribution of the HLA region to familial clustering of coeliac disease. Ann Hum Genet 1997;61:307-17.
18. Bevan S, Popat S, Braegger CP, Busch A et al. Contribution of the MHC region to the familial risk of coeliac disease. J Med Genet 1999;36: 687-90.
19. Dijilali-Saiah I, Schmitz J, Harfouch-Hammond E, Mougenot JF et al.: CTLA-4 gene polymorphism is associated with predisposition in coeliac disease. Gut 1998;43:187-9.
20. Nalui AT, Nilsson S, Samuelsson L, Gudjonsdottir AH et al. The CTLA-4/CD28 gene region on chromosome 2q33 confers susceptibility to coeliac disease in a way possibly distinct from that of type I diabetes and other chronic inflammatory disorders. Tissue Antigens 2000;56:350-5.
21. Holopainen P, Arvas M, Sistonen P, Mustalahti K et al. CD28/CTLA-4 gene region on chromosome 2q33 confers genetic susceptibility to coeliac disease: a linkage and family-based association study. Tissue Antigens 1999;53:470-5.
22. King AL, Moodie SJ, Fraser JS, Curtis D et al. CTLA4/CD28 gene region is associated with genetic susceptibility to coeliac disease in UK families. J Med Genet 2002;39:51-4.
23. Waterhouse P, Penninger JM, Timms E, Wakeham A et al. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 1995;270:985-8.
24. Braun J, Donner H, Siegmund T, Walfish IG et al. CTLA-4 promotor variants in patients with Grave's disease and Hashimoto's thyroiditis. Tissue Antigens 1998;51:563-6.
25. Marron MP, Raffel LJ, Garchon HJ, Jacob CO et al. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA-4 polymorphisms in multiple ethnic groups. Hum Mol Genet 1997;6:1275-82.
26. Gjerstsen HA, Lundin KE, Sollid LM, Eriksen JA, Thorsby E. T cells recognize a peptide derived from alpha-gliadin presented by the coeliac disease-associated HLA-DQ (alpha 1*0501, beta 1*0201) heterodimers. Hum Immunol 1994;39(4):243-52.
27. Lundin KE, Sollid LM, Anthonsen D, Noren O et al. Heterogeneous reactivity patterns of HLA-DQ-restricted, small intestinal T-cell clones from patients with coeliac disease. Gastroenterology 1997; 112(3):752-9.
28. Picarlli A, Di Tola M, Sabbatella L, Anania MC et al. 31-43 amino acid sequence of the alpha-gliadin induces anti-endomysial antibody production during in vitro challenge. Scand J Gastroenterol 1999; 34(11):1099-102.
29. Shidrawi RG, Day P, Przemioslo R, Ellis HJ et al. In vitro toxicity of gluten peptides in coeliac disease assessed by organ culture. Scand J Gastroenterol 1995;30(8):758-63.
30. Van De WY, Kooy YM, van Veelen PA, Pena SA et al. Small intestinal T cells of coeliac disease patients recognize a natural pepsin fragment of gliadin. Proc Natl Acad Sci USA 1998;95(17):10050-4.
31. Van De WY, Kooy YM, Van Veelen P, Vader W et al. Glutenin is involved in the gluten-driven mucosal T cell response. Eur J Immunol 1999; 29(10):3133-9.
32. Sturgess R, Day P, Ellis HJ, Lundin KE et al. Wheat peptide challenge in coeliac disease. Lancet 1994;343(8900):758-61.
33. Anderson RP, Degano P, Godkin AJ, Jewell DP, Hill AV. In vivo antigen challenge in coeliac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med 2000;6(3):337-42.
34. Arentz-Hansen H, Korner R, Molberg O, Quarsten H et al. The intestinal T cell response to alpha-gliadin in adult coeliac disease is focussed on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 2000;191(4):603-12.
35. Sollid L. Molecular basis of celiac. Annu Rev Immunol 2000;18:53-81.
36. Fraser JS, Engels, W, Pollock EL, Moodie SJ et al. In vivo toxicity of amino acids 56-75 of A-gliadin in coeliac disease. Gut 2002;50 (Suppl 11):A19.